You are here: Industry Insights > Strides Pharma

News List

Strides Pharma’s Singapore arm gets US FDA nod for generic version of oseltamivir phosphate ExpressPharma
January 19, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Tamiflu for oral suspension, 6 mg/mL, of Hoffmann-La Roche, Inc.
Cipla, Strides Pharma recall drugs in the US market expresspharma
January 11, 2021
Cipla has recalled packets of esomeprazole magnesium for delayed-release oral suspension while Strides Pharma has recalled Tacrolimus capsules.
Sun Pharma, Strides Pharma recall drugs in the US expresspharma
October 12, 2020
Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280 bottles of potassium chloride extended-release tablets due to failed dissolution specifications.
USFDA approves prednisone tablets from Strides Pharma expresspharma
September 04, 2020
Prednisone is a corticosteroid used in treatment of different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders.
SeQuent Scientific to sell stake in Strides Pharma expresspharma
August 14, 2020
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573 million.
Strides receives USFDA approval for headache drug expresspharma
July 10, 2020
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules will be marketed by Strides Pharma in the US market.
Strides Pharma Q4 results: Posts net loss of Rs 206.57 crore expresspharma
May 21, 2020
The company's consolidated revenue from operations stood at Rs 618.64 crore for the quarter under consideration. It was Rs 616.18 crore for the same period year ago, it added.
Strides Pharma Science arm gets USFDA nod for anti-epileptic drug expressbpd
February 21, 2019
The approved product is a generic version of Zarontin Capsules, 250 mg, of Pfizer
Strides receives USFDA approval for Potassium Chloride Extended Release tablets financialexpress
September 06, 2018
The product will be launched immediately by Strides Pharma in the US markets
Strides Pharma receives USFDA nod for two key ANDAs biospectrumasia
August 24, 2018
The USFDA also granted Strides’ request to designate the drug product under these ANDAs as a Competitive Generic Therapy (CGT)